Zacks Q3 Preview Lacks Specifics; NDAQ Thesis Unchanged Pending Earnings

What happened

A Zacks article published on October 22, 2026 previews Nasdaq's Q3 2026 earnings, noting that headline numbers and key metrics relative to estimates will be important, but the article itself contains no actual figures or analysis. The DeepValue master report from July 2026 remains the baseline, showing Q2 revenue less transaction-based expenses up 14.9% year over year, Solutions revenue up 17%, and total ARR up 12% organically. The investment thesis still depends on Financial Technology ARR sustaining mid-teens growth and Capital Access ARR holding high single digits, with 23/5 trading and new product monetization as secondary catalysts. The stock trades at 27.7x earnings and 19.9x EV/EBITDA, so the market is already pricing in steady software-driven compounding. Until actual Q3 results are released, there is no new fundamental information to adjust the thesis.

Implication

The lack of concrete Q3 data means the premium multiple remains vulnerable to any sign of deceleration in Financial Technology ARR or Capital Access ARR. If Q3 results show FinTech organic ARR at or above 15% and cross-sell momentum intact, the stock's current price near $96 is justified, and a pullback toward $90 would offer an attractive entry. Conversely, if organic ARR falls toward 12% or operating-company IPO weakness persists, the stock could de-rate toward the bear-case implied value of $84. Investors should monitor the December 6, 2026 SIP overnight readiness deadline, as any delay could undermine the 23/5 narrative. Until Q3 numbers are disclosed, maintaining a neutral-to-cautious stance is prudent, with a buy-the-dip approach rather than chasing strength.

Thesis delta

The thesis remains unchanged: Nasdaq is a diversified market infrastructure company whose near-term value depends on software and index recurring revenue growth, not on trading volumes or new product launches. The Zacks article adds no new data, so there is no basis to adjust the probability-weighted scenarios or the attractive entry level of $90. The next checkpoint is the actual Q3 earnings release, where FinTech ARR growth and cross-sell activity will be the key indicators.